Excessive irritability

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Presentation[edit | edit source]

Prevalence[edit | edit source]

  • Katrina Berne reports a prevalence of 70-90% for mood swings, excessive irritability, and overreaction in people with chronic fatigue syndrome.[1]

Symptom recognition[edit | edit source]

  • In the Holmes criteria, excessive irritability is an optional criteria for diagnosis, under the section Minor Symptom Criteria - Neuropsychologic Complaints.[2]

Notable studies[edit | edit source]

Possible causes[edit | edit source]

Potential treatments[edit | edit source]

Severe irritability is a common symptom in autism, and the main treatment for this is atypical anti-psychotic drugs such as amisulpride (Solian), risperidone (Risperdal) or aripiprazole (Abilify).[3] Very low dose amisulpride has also been shown to reduce the fatigue and bodily symptoms of ME/CFS[4]. N-acetyl-cysteine can help the irritability in autism, but the research showed this is not quite as effective as atypical anti-psychotics.[5]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Berne, Katrina (December 1, 1995). Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS) (2nd ed.). Hunter House. p. 60. ISBN 978-0897931915.
  2. The 1988 Holmes Definition for CFS
  3. Posey, David J.; Stigler, Kimberly A.; Erickson, Craig A.; McDougle, Christopher J. (January 2, 2008). "Antipsychotics in the treatment of autism". The Journal of Clinical Investigation. 118 (1): 6–14. doi:10.1172/JCI32483. ISSN 0021-9738. PMC 2171144. PMID 18172517.
  4. Pardini, Matteo; Guida, Silvia; Primavera, Alberto; Krueger, Frank; Cocito, Leonardo; Gialloreti, Leonardo Emberti (March 2011). "Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study". European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology. 21 (3): 282–286. doi:10.1016/j.euroneuro.2010.10.008. ISSN 1873-7862. PMID 21112746.
  5. Hardan, Antonio Y.; Fung, Lawrence K.; Libove, Robin A.; Obukhanych, Tetyana V.; Nair, Surekha; Herzenberg, Leonore A.; Frazier, Thomas W.; Tirouvanziam, Rabindra (June 2012). "A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism". Biological Psychiatry. 71 (11): 956–961. doi:10.1016/j.biopsych.2012.01.014. ISSN 0006-3223. PMC 4914359. PMID 22342106.